The peptide F3, which targets the tumor cell surface receptor nucleolin, enhances uptake of the fluorescent polyacrylamide nanoparticles in glioma cells by a factor of 3.1 compared to nanoparticles without F3 [73]. Here, NUCLEOLIN is linked to central nervous system cancer.